Literature DB >> 24476348

PT/NBL ratio assessment at mid-trimester in prenatal screening for Down syndrome in a Chinese population.

Xin Yang1, Li Zhen, Min Pan, Jin Han, Dongzhi Li, Can Liao.   

Abstract

OBJECTIVE: To investigate the ratio of prenasal thickness (PT) to nasal bone length (NBL) in normal and trisomy 21 fetuses in the second and third trimester in Chinese population.
METHODS: The NBL and PT were measured blindly by using 3D volumes in 143 normal fetuses and 31 trisomy 21 fetuses.
RESULTS: The mean PT (r = 0.83, p = 0.004) and NBL (r = 0.87, p = 0.0062) both increased with the gestation age, while the PT/NBL ratio (r = 0.12, p > 0.10) remained stable. There was significant difference between normal and trisomy 21 fetuses (p < 0.001). If we took the 95th of the normal fetuses as the cut-off value, the detection rate was only 46%. By using ROC curve to evaluate the screening value of PT/NBL ratio, the area under receiver operating characteristic (ROC) curve was 0.88 (95% confidence interval 0.81 to 0.94, p < 0.0001).
CONCLUSIONS: In Chinese population, the PT/NBL ratio is not a very strong ultrasound marker to predict trisomy 21 fetuses. However, it can be used as an ultrasound marker for Down syndrome screening during the second and third trimester of pregnancy.

Keywords:  Chinese population; nasal bone length; prenasal thickness; screening; trisomy 21

Mesh:

Year:  2014        PMID: 24476348     DOI: 10.3109/14767058.2014.885944

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women.

Authors:  Yan Du; Yunyun Ren; Yingliu Yan; Li Cao
Journal:  Acta Obstet Gynecol Scand       Date:  2017-12-14       Impact factor: 3.636

2.  Utility of fetal facial markers on a second trimester genetic sonogram in screening for Down syndrome in a high-risk Thai population.

Authors:  Savitree Pranpanus; Kanokkarn Keatkongkaew; Manaphat Suksai
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-11       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.